GGrantIndex
← Search

NK1 ANTAGONIST GR205171 &IN COMBINATION W ONDANSETRON

$0M01FY2000RRNIH

Pennsylvania State Univ Hershey Med Ctr, Hershey PA

Investigators

Linked publications & trials

Abstract

The purpose of this study is to evaluate the effectiveness of a single intravenous dose of GR205171-25 mg alone or in combination with IV ondansetron-4mg or IV ondansetron 4 mg alone or placebo IV for the treatment of morphine induced nausea and to evaluate the effect of these treatment groups on changes in symptoms associated with morphine induced nausea.

View original record on NIH RePORTER →